No Data
No Data
Great Week for Edwards Lifesciences Corporation (NYSE:EW) Institutional Investors After Losing 2.4% Over the Previous Year
Morgan Stanley Downgrades Edwards Lifesciences(EW.US) to Hold Rating, Cuts Target Price to $70
Edwards Lifesciences Resumed With an Equal Weight at Morgan Stanley
Edwards Lifesciences Soars on TTVR Approval, But Challenges Remain
Edwards Lifesciences Is Maintained at Outperform by RBC Capital
Edwards Lifesciences Call Volume Above Normal and Directionally Bullish
No Data
No Data